Trending Now
The FDA Accepts an NDA for umbralisib From TG Therapeutics Inc...
From the beginning, TG Therapeutics Inc common stock (NASDAQ:TGTX) has always had big dreams of challenging the status quo of drug development. Over the...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Metaverse Small Caps Poised After Goldman Sachs Points to $8 Trillion...
The metaverse theme has been percolating in the integumentary tissue of the market since Facebook changed its name to Meta Platforms Inc....
MAKE IT MODERN
LATEST REVIEWS
Tongji Healthcare Group Inc (OTCMKTS:TONJ) Closes Clubhouse Acquisition Becoming Dominant Social...
Tongji Healthcare Group Inc (OTCMKTS:TONJ) is as interesting a story on the OTC right as one might hope to find. The social media influencer...
MAKE IT MODERN
PERFORMANCE TRAINING
Cassava Sciences Inc (NASDAQ:SAVA) Expects To Release Clinical Results Of Phase 2b Trial To...
Cassava Sciences Inc (NASDAQ:SAVA) reported a net loss of $1.1 million in Q2 2020. The company expects to use $5 million in 2020 for...
ABVC BioPharma Inc. (NASDAQ: ABVC) Announces Q3 2021 Net loss of $1.9M and Nasdaq...
ABVC BioPharma Inc. (NASDAQ: ABVC) has announced its operating and financial Q3 2021, ending September 30, 2021.
Q3 revenue of $98,999
Revenue in Q3 2021 was...
Leap Therapeutics Inc. (NASDAQ: LPTX) Announces Q3 2021 Financial Results and Closes $103.6 Million...
Leap Therapeutics Inc. (NASDAQ: LPTX) has announced its third-quarter financial results for the quarter ending September 30, 2021.
Leap closed a $103.6 million public offering.
During...
Quantum Corporation (QMCO): Revolutionizing Data Protection with the DXi9200 to Strengthen Cyber Resilience
Quantum Corporation (NASDAQ: QMCO), a leader in end-to-end data management solutions for the AI era, is making waves in the tech sector...
Entera Unveils EB613 Phase 2 Biomarker Data
Entera Bio Ltd has been focusing on its Phase 2 clinical trial involving EB613, and it is impressed with the progress so far. The...
MAKE IT MODERN
